Innovent Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryInnovent Biologics Inc Innovent Biologics is a biopharmaceutical company that discovers develops and manufactures monoclonal antibodies. The company's product portfolio comprise monoclonal...
View ArticleInDex Pharmaceuticals Holding AB publ Year end Report 2016
STOCKHOLM Feb 27 2017 PRNewswire Period October December 2016 Revenues amounted to SEK 0.3 0.1 million Operating result amounted to SEK 16.4 6.4 million Result after tax amounted to SEK 16.3 6.5...
View ArticleChemoCentryx Inc CCXI Financial and Strategic SWOT Analysis Review Updated...
SummaryChemoCentryx Inc ChemoCentryx discovers develops and commercializes orallyadministered therapeutics for the treatment of cancer autoimmune diseases and inflammatory disorders with major focus on...
View ArticleIncontinence and Ostomy Care Global Market Forecast to 2023 Updated 15022017...
Incontinence and ostomy care consist of products that are essential for patients with incontinence and stoma. With the projected rise in aged population and awareness about such conditions the market...
View ArticleColorectal Cancer Heat Map and Analysis Updated 01022017 Prices from USD $2000
Colorectal Cancer Heat Map and AnalysisSummaryColorectal cancer CRC otherwise known as bowel cancer is a malignancy originating in the colon the large intestine or rectum both of which are located...
View ArticleNeovacs SA ALNEV Financial and Strategic SWOT Analysis Review Updated...
SummaryNeovacs SA Neovacs develops various vaccines. The company offers TNF kinoid and IFNa kinoid products used for the treatment of rheumatoid arthritis Crohn's disease cancer; and systemic lupus...
View ArticleGlobal Crohn's Disease Partnering 2010 to 2017 Updated 01022017 Prices from...
The Global Crohn's Disease Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare...
View ArticleImmune Pharmaceuticals Reports Encouraging Preliminary Data with Bertilimumab...
NEW YORK Feb. 28 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP "Immune" or the "Company" today announced that it has broadened enrollment eligibility criteria based on the data reported from...
View ArticleLilly to Present New Data for Taltz ixekizumab in Psoriasis and Psoriatic...
INDIANAPOLIS Feb. 28 2017 PRNewswire Eli Lilly and Company NYSE LLY will highlight new Phase 3 data evaluating Taltz ixekizumab for the treatment of moderatetosevere plaque psoriasis and active...
View ArticleEdison Issues Outlook on TxCell TXCL
LONDON February 28 2017 PRNewswire TxCell's novel CARmodified regulatory Tcell CAR Treg platform is developing well. CAR Tregs offer a powerful and versatile new approach to autoimmune and immune...
View ArticleInfliximab vs. Adalimumab in Crohn's Disease
Do the antiTNF agents infliximab and adalimumab have comparable response characteristics Are concomitant immunomodulators necessary for optimal response Alimentary Pharmacology & Therapeutics
View ArticleTxCell TXCL Exciting CAR opportunities; multiple indications
Edison Investment Research Pharmaceutical & healthcare TxCell TxCell’s novel CARmodified regulatory Tcell CAR Treg platform is developing well. CAR Tregs offer a powerful and versatile...
View ArticleAcibadem Saglik Hizmetleri ve Ticaret AS Pharmaceuticals Healthcare Deals and...
SummaryAcibadem Saglik Hizmetleri ve Ticaret AS Acibadem is a healthcare service provider that offers diagnosis and treatment services. The center offers aesthetic plastic and reconstructive surgery;...
View ArticleArticles Prediction of complicated disease course for children newly...
Our findings support the usefulness of risk stratification of paediatric patients with Crohn's disease at diagnosis and selection of antiTNF therapy.
View ArticleComment RISK stratification in paediatric Crohn's disease
Speak up. Step up. Stand out. With this slogan for the fifth annual Crohn's and Colitis Awareness Week the Crohn's & Colitis Foundation of America was asking everyone to raise awareness of Crohn's...
View ArticleKids with Crohn's Benefit from Risk Model for Complications CMECE
MedPage Today Seen as helpful in deciding whether to use antiTNF drugs
View ArticleCrohn's and Colitis Foundation of America RISK Stratification Study Reveals...
Life Sciences Jobs ...
View ArticleStudy reveals complication predictors in children with Crohn's disease
Researchers have successfully identified biological signatures in pediatric patients with newly diagnosed Crohn's disease CD capable of predicting whether a child will develop diseaserelated...
View ArticleCrohn's & Colitis Foundation RISK Stratification Study Reveals Potential New...
NEW YORK March 2 2017 PRNewswireUSNewswire Researchers have successfully identified biological signatures in pediatric patients with newly diagnosed Crohn's disease CD capable of predicting whether a...
View ArticleProtagonist Therapeutics to Present at the Barclays Global Healthcare Conference
MILPITAS Calif. March 2 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today announced that Dinesh V. Patel Ph.D. the Company's President and Chief Executive Officer will provide a corporate...
View Article